Identification of FCER1G related to Activated Memory CD4+ T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma

被引:2
作者
Xiang, Xiaoyu [1 ]
Gao, Li-Min [1 ]
Zhang, Yuehua [1 ]
Tang, Yuan [1 ]
Zhao, Sha [1 ]
Liu, Weiping [1 ]
Ye, Yunxia [1 ]
Zhang, Wenyan [1 ]
机构
[1] Sichuan Univ, Dept Pathol, West China Hosp, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
diffuse large B-cell lymphoma; weighted gene co-expression network analysis; memory activated CD4(+) T cells; prognosis biomarkers; FCER1G; R PACKAGE; EXPRESSION; PROGRESSION; INHIBITION; SUBGROUPS; PROGNOSIS; APOPTOSIS; SURVIVAL; ESCAPE; TISSUE;
D O I
10.3389/fgene.2022.849422
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Diffuse large B cell lymphoma (DLBCL) is a group of biologically heterogeneous tumors with different prognoses. The tumor microenvironment plays a vital role in the tumorigenesis and development of DLBCL, and activated memory CD4(+) T cells are an essential component of immunological cells in the lymphoma microenvironment. So far, there are few reports about activated memory CD4+T cells infiltration and related genes in the DLBCL tumor microenvironment. This study obtained the mRNA expression profile information of the testing GSE87371 dataset and another six validation datasets (GSE53786, GSE181063, GSE10846, GSE32918, GSE32018, GSE9327, GSE3892, TCGA-DLBC) from the GEO and TCGA databases. Weighted Gene Co-expression Network Analysis (WGCNA) screened gene module associated with activated memory CD4(+) T cells infiltration. CIBERSORT and TIMER (immune cells infiltrating estimation analysis tools) were used to identify the relationship between activated memory CD4(+) T cells and genes associated with immune infiltrating cells in the tumor microenvironment. The least absolute shrinkage and selection operator (LASSO) built the risk prediction model and verified it using nomogram and Kaplan-Meier analysis. Further functional characterization includes Gene Ontology, KEGG pathway analysis and Gene Set Enrichment Analysis (GSEA) to investigate the role and underlying mechanisms of these genes. These results suggest that the expression of FCER1G can reflect the invasion of activated memory CD4(+) T cells in DLBCL, which provides a new idea for studying the tumor microenvironment and may become a potential predictive biomarker for the assessment of DLBCL.
引用
收藏
页数:16
相关论文
共 63 条
  • [11] Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
    Dubois, Sydney
    Viailly, Pierre-Julien
    Bohers, Elodie
    Bertrand, Philippe
    Ruminy, Philippe
    Marchand, Vinciane
    Maingonnat, Catherine
    Mareschal, Sylvain
    Picquenot, Jean-Michel
    Penther, Dominique
    Jais, Jean-Philippe
    Tesson, Bruno
    Peyrouze, Pauline
    Figeac, Martin
    Desmots, Fabienne
    Fest, Thierry
    Haioun, Corinne
    Lamy, Thierry
    Copie-Bergman, Christiane
    Fabiani, Bettina
    Delarue, Richard
    Peyrade, Frederic
    Andre, Marc
    Ketterer, Nicolas
    Leroy, Karen
    Salles, Gilles
    Molina, Thierry J.
    Tilly, Herve
    Jardin, Fabrice
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2232 - 2244
  • [12] T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
    Facciabene, Andrea
    Motz, Gregory T.
    Coukos, George
    [J]. CANCER RESEARCH, 2012, 72 (09) : 2162 - 2171
  • [13] T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large-B-cell lymphomas
    Felgar, RE
    Steward, KR
    Cousar, JB
    Macon, WR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (06) : 1707 - 1715
  • [14] The immune contexture in human tumours: impact on clinical outcome
    Fridman, Wolf Herman
    Pages, Franck
    Sautes-Fridman, Catherine
    Galon, Jerome
    [J]. NATURE REVIEWS CANCER, 2012, 12 (04) : 298 - 306
  • [15] Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
    Fu, Lin
    Cheng, Zhiheng
    Dong, Fen
    Quan, Liang
    Cui, Longzhen
    Liu, Yan
    Zeng, Tiansheng
    Huang, Wenhui
    Chen, Jinghong
    Pang, Ying
    Ye, Xu
    Wu, Guangsheng
    Qian, Tingting
    Chen, Yang
    Si, Chaozeng
    [J]. JOURNAL OF CANCER, 2020, 11 (05): : 1182 - 1194
  • [16] PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
    Gomez-Abad, Cristina
    Pisonero, Helena
    Blanco-Aparicio, Carmen
    Roncador, Giovanna
    Gonzalez-Menchen, Alberto
    Martinez-Climent, Jose A.
    Mata, Eva
    Elena Rodriguez, Maria
    Munoz-Gonzalez, Guillermo
    Sanchez-Beato, Margarita
    Leal, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    [J]. BLOOD, 2011, 118 (20) : 5517 - 5527
  • [17] Polymorphisms in innate immunity genes and risk of childhood leukemia
    Han, Sohee
    Lan, Qing
    Park, Ae Kyung
    Lee, Kyoung-Mu
    Park, Sue K.
    Ahn, Hyo Seop
    Shin, Hee Young
    Kang, Hyoung Jin
    Koo, Hong Hoe
    Seo, Jong Jin
    Choi, Ji Eun
    Ahn, Yoon-Ok
    Chanock, Stephen J.
    Kim, Ho
    Rothman, Nathaniel
    Kang, Daehee
    [J]. HUMAN IMMUNOLOGY, 2010, 71 (07) : 727 - 730
  • [18] The Gene Ontology (GO) database and informatics resource
    Harris, MA
    Clark, J
    Ireland, A
    Lomax, J
    Ashburner, M
    Foulger, R
    Eilbeck, K
    Lewis, S
    Marshall, B
    Mungall, C
    Richter, J
    Rubin, GM
    Blake, JA
    Bult, C
    Dolan, M
    Drabkin, H
    Eppig, JT
    Hill, DP
    Ni, L
    Ringwald, M
    Balakrishnan, R
    Cherry, JM
    Christie, KR
    Costanzo, MC
    Dwight, SS
    Engel, S
    Fisk, DG
    Hirschman, JE
    Hong, EL
    Nash, RS
    Sethuraman, A
    Theesfeld, CL
    Botstein, D
    Dolinski, K
    Feierbach, B
    Berardini, T
    Mundodi, S
    Rhee, SY
    Apweiler, R
    Barrell, D
    Camon, E
    Dimmer, E
    Lee, V
    Chisholm, R
    Gaudet, P
    Kibbe, W
    Kishore, R
    Schwarz, EM
    Sternberg, P
    Gwinn, M
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 : D258 - D261
  • [19] Time-dependent ROC curves for censored survival data and a diagnostic marker
    Heagerty, PJ
    Lumley, T
    Pepe, MS
    [J]. BIOMETRICS, 2000, 56 (02) : 337 - 344
  • [20] Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
    Hiraoka, K
    Miyamoto, M
    Cho, Y
    Suzuoki, M
    Oshikiri, T
    Nakakubo, Y
    Itoh, T
    Ohbuchi, T
    Kondo, S
    Katoh, H
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (02) : 275 - 280